Cargando…
Stromal cells downregulate miR-23a-5p to activate protective autophagy in acute myeloid leukemia
Complex molecular cross talk between stromal cells and the leukemic cells in bone marrow is known to contribute significantly towards drug-resistance. Here, we have identified the molecular events that lead to stromal cells mediated therapy-resistance in acute myeloid leukemia (AML). Our work demons...
Autores principales: | Ganesan, Saravanan, Palani, Hamenth Kumar, Lakshmanan, Vairavan, Balasundaram, Nithya, Alex, Ansu Abu, David, Sachin, Venkatraman, Arvind, Korula, Anu, George, Biju, Balasubramanian, Poonkuzhali, Palakodeti, Dasaradhi, Vyas, Neha, Mathews, Vikram |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6769009/ https://www.ncbi.nlm.nih.gov/pubmed/31570693 http://dx.doi.org/10.1038/s41419-019-1964-8 |
Ejemplares similares
-
A phase II study evaluating the role of bortezomib in the management of relapsed acute promyelocytic leukemia treated upfront with arsenic trioxide
por: Kulkarni, Uday, et al.
Publicado: (2020) -
Metabolic adaptation drives arsenic trioxide resistance in acute promyelocytic leukemia
por: Balasundaram, Nithya, et al.
Publicado: (2022) -
Haploidentical Natural Killer Cell Therapy as an Adjunct to Stem Cell Transplantation for Treatment of Refractory Acute Myeloid Leukemia
por: Kulkarni, Uday, et al.
Publicado: (2023) -
Management of relapse in acute promyelocytic leukaemia treated with up‐front arsenic trioxide‐based regimens
por: Fouzia, N. A., et al.
Publicado: (2020) -
Arsenic Trioxide Enhances the NK Cell Cytotoxicity Against Acute Promyelocytic Leukemia While Simultaneously Inhibiting Its Bio-Genesis
por: Alex, Ansu Abu, et al.
Publicado: (2018)